 |
ZEISS ARTEVO 750 and ZEISS ARTEVO 850 surgical microscopes present ophthalmic surgeons in China with end-to-end workflow integration to enhance effectivity, precision, and surgical security.
JENA, Germany and SHANGHAI, Feb. 3, 2026 /PRNewswire/ — ZEISS Medical Expertise introduced at this time that China’s Nationwide Medical Merchandise Administration (NMPA) has authorised the ZEISS ARTEVO 750 and ARTEVO 850 ophthalmic microscopes. The microscopes present prime quality optical and digital visualization for each anterior and posterior segments. With upgrades spanning each {hardware} and software program, the newly authorised microscopes supporting ophthalmic surgical procedures guarantee extra exact operations and higher surgical security with enhanced decision, RGB illumination and full compatibility with the newest era of ZEISS’s cataract workflow.
ZEISS ARTEVO 750
“The introduction of ZEISS ARTEVO 750 and ARTEVO 850 microscopes powerfully demonstrates our dedication to ophthalmologists in China. We’ll leverage the ability of innovation to contribute to the development of eye well being in China and higher serve Chinese language surgeons and their sufferers,” says Martin Fischer, President & CEO of ZEISS Larger China.
The ZEISS ARTEVO 750 ophthalmic microscope is one other breakthrough in ZEISS’s ophthalmic surgical microscope household that made its Chinese language debut on the 2025 China Worldwide Import Expo (CIIE). Combining superior expertise with established optical experience, the ARTEVO 750 permits surgeons to finetune their surgical views in routine and complicated procedures, together with cataract & vitreoretinal surgical procedure, corneal transplantation, and minimally invasive glaucoma surgical procedure (MIGS). With enhanced decision, elevated depth of subject, clever RGB illumination and intraoperative OCT, the ZEISS ARTEVO 750 helps wonderful usability and a seamless end-to-end workflow.
“The improved optical decision of the ARTEVO 750 permits us to raise our capabilities in performing delicate ophthalmic surgical procedures,” states Professor Chen Jili from Shanghai Jing’an District Shibei Hospital.
The ZEISS ARTEVO 850 is a 3D-enabled digital microscope designed for a number of specialties in ophthalmology, setting the tempo in digital visualization. It combines the confirmed advantages of a digital ophthalmic microscope with customizable 3D digital visualization, useful integration, wonderful usability, and integration right into a complete medical ecosystem. Digital Colour Assistant (DCA) enhances colours within the surgical picture to intensify anatomical particulars. One other benefit of digital visualization contains optimization of the depth of subject as much as 60%1 with Good Depth of Area (DoF) perform. A redesigned person interface for ZEISS CALLISTO eye centralizes all controls onto a single intuitive touchscreen. Digital integration into ZEISS ophthalmic workflows permits for seamless information switch, with reference picture matching instantly on the 3D display screen and a markerless toric IOL implantation that may be absolutely surgeon managed.
Professor Xu Gezhi from the EENT Hospital of Fudan College explains, “The decision of the ARTEVO 850 is really wonderful, and the clear visibility and decreased fatigue in the course of the surgical procedure make the expertise very nice.”
The provision in China of the following era of ZEISS ophthalmic microscopes, together with the ZEISS ARTEVO 750 and ARTEVO 850, helps remodel the surgical expertise with superior optics and capabilities.
The ZEISS ARTEVO 850 might be showcased as a part of ZEISS’s ophthalmic workflows within the ZEISS sales space #5FG-J01 on the 41st Asia-Pacific Academy of Ophthalmology (APAO) convention in Hong Kong from February 5-8, 2026. For extra details about ZEISS ophthalmic surgical microscopes, go to right here.
1 Knowledge on file. In comparison with ZEISS ARTEVO 800.
Not all merchandise, providers or affords are authorised or supplied in each market and authorised labeling and directions could differ from one nation to a different. For country-specific product data, see the suitable nation web site. Product specs are topic to vary in design and scope of supply on account of ongoing technical improvement. The statements of the healthcare professionals mirror solely their private opinions and experiences and don’t essentially mirror the opinion of any establishment that they’re affiliated with. The healthcare professionals alone are accountable for the content material of their expertise reported and any potential ensuing infringements. Carl Zeiss Meditec AG and its associates to not have scientific proof supporting the opinions and statements of the well being care professionals nor settle for any duty or legal responsibility of the healthcare professionals’ content material. The healthcare professionals have a contractual or different monetary relationship with Carl Zeiss Meditec AG and its associates and have acquired monetary assist.
Contact for buyers
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Telephone: +49 3641 220 116
Mail: buyers.med@zeiss.com
Contact for the press
Frank Smith
Head of International Communications
Ophthalmology, Carl Zeiss Meditec Inc.
Telephone: +49 3641 220 331
Mail: press.med@zeiss.com
www.zeiss.com/newsroom
Temporary Profile
Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German inventory trade, is among the world’s main medical expertise corporations. The Firm provides modern applied sciences and application-oriented options designed to assist docs enhance the standard of lifetime of their sufferers. The Firm affords full options, together with implants and consumables, to diagnose and deal with eye ailments. The Firm creates modern visualization options within the subject of microsurgery. With 5,730 workers worldwide, the Group generated income of €2,066.1m in fiscal 12 months 2023/24 (to 30 September).
The Group’s head workplace is situated in Jena, Germany, and it has subsidiaries in Germany and overseas; greater than 50 p.c of its workers are based mostly within the USA, Japan, Spain and France. The Middle for Utility and Analysis (CARIn) in Bangalore, India and the Carl Zeiss Improvements Middle for Analysis and Improvement in Shanghai, China, strengthen the Firm’s presence in these quickly creating economies. Round 39 p.c of Carl Zeiss Meditec AG’s shares are in free float. Approx. 59 p.c are held by Carl Zeiss AG, one of many world’s main teams within the optical and optoelectronic industries.
For additional data go to: www.zeiss.com/med
ZEISS ARTEVO 850
